Welcome to our dedicated page for Rcm Tech news (Ticker: RCMT), a resource for investors and traders seeking the latest updates and insights on Rcm Tech stock.
RCM Technologies, Inc. (NasdaqGM: RCMT) is regularly featured in corporate news for its role as a business and technology solutions provider focused on enhancing customer operational performance. Company press releases highlight activity across its three reporting segments—Specialty Health Care, Engineering and Life Sciences, Data and Solutions—as well as broader service areas such as Health Care, Aerospace & Defense, Process & Industrial, Life Sciences and Data & Solutions.
News coverage for RCMT commonly includes quarterly and annual earnings announcements. These releases provide detail on revenue, gross profit, operating income, net income and segment performance, along with reconciliations of GAAP results to non-GAAP metrics such as Adjusted operating income, EBITDA, Adjusted EBITDA, Adjusted net income and Adjusted diluted net earnings per share. Management commentary in these reports often discusses segment trends, backlog in Engineering, momentum in Healthcare and the company’s expectations for future periods, framed within the context of forward-looking statements.
Other frequent news items involve conference call announcements, where RCM schedules teleconferences to discuss financial results for specific reporting periods. The company also issues releases on corporate developments, such as its addition to the Russell 3000 and Russell 2000 Indexes and the expansion of its Human Capital Management activities through RCM HCM Solutions, including a value-added reseller program for the UKG Ready suite.
Investors and followers of RCMT news can use this page to review historical and recent press releases related to financial performance, segment updates, index membership, auditor changes disclosed via Form 8-K, and strategic initiatives in areas like workforce technology. Regularly reviewing these updates can help readers understand how RCM’s Specialty Health Care, Engineering and Life Sciences, Data and Solutions segments contribute to overall results and how the company positions itself in its stated end markets.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
RCM Technologies (NasdaqGM: RCMT) reported strong financial results for Q4 and FY 2022, achieving revenue of $70.2 million for the quarter, up 8.2% year-over-year, and $284.7 million for the year, reflecting a 39.6% increase. Gross profit rose to $20.5 million in Q4, a 15.0% increase, while annual gross profit hit $82.9 million, up 56.1%. Despite a decrease in GAAP net income to $4.8 million or $0.48 per diluted share for Q4, adjusted EBITDA grew to $7.0 million for the quarter and $29.5 million for the year. The company generated over $28 million in cash flow from operations in 2022, indicating strong operational performance.
RCM Technologies, Inc. (NasdaqGM: RCMT) has announced a conference call scheduled for March 16, 2023, at 11:00 a.m. Eastern Time. The purpose is to discuss the financial results for the thirteen and fifty-two weeks ended December 31, 2022. Callers can join via dial-in at (800) 285-6670 for domestic or (713) 936-6995 for international participation. RCM provides business and technology solutions to optimize performance in commercial and government sectors, alongside specialty healthcare services. Risks and uncertainties linked with forward-looking statements regarding performance and growth are highlighted.